Maryanski J L, Marchand M, Uyttenhove C, Boon T
Int J Cancer. 1983 Jan 15;31(1):119-23. doi: 10.1002/ijc.2910310119.
After mutagenesis of mouse mastocytoma P815, it is possible to obtain variant (tum-) clones that are almost always rejected by syngeneic DBA/2 mice. Most tum- clones express new variant-specific antigens that can be detected by cytolytic T cells (CTL). Occasionally, mice injected with tum- variants eventually develop progressive tumors. Cells from these tumors were analyzed for antigen expression with variant-specific and P815-specific CTL clones. Out of 13 tumors examined, 11 were composed of cells that had clearly lost a variant-specific antigenic determinant. These results indicate that tum- variants induce a specific host rejection response which usually results in complete elimination of the variant cells, but that occasional antigen-loss constitutes an important mechanism of escape. The loss of a variant-specific antigenic determinant from one tum- clone that had escaped rejection allowed the detection of a residual variant-specific determinant. This was demonstrated by isolating a new CTL clone that lysed both the original tum- clone and its antigen-loss variant, but not other P815 targets. Thus, some complex transplantation antigens can be separated into independent determinants by using antigen-loss variants.
对小鼠肥大细胞瘤P815进行诱变后,有可能获得几乎总是被同基因DBA/2小鼠排斥的变异(肿瘤-)克隆。大多数肿瘤-克隆表达新的变异特异性抗原,这些抗原可被细胞毒性T细胞(CTL)检测到。偶尔,注射肿瘤-变异体的小鼠最终会发展为进行性肿瘤。用变异特异性和P815特异性CTL克隆分析这些肿瘤的细胞抗原表达。在检查的13个肿瘤中,11个由明显失去变异特异性抗原决定簇的细胞组成。这些结果表明,肿瘤-变异体诱导特异性宿主排斥反应,通常导致变异细胞被完全清除,但偶尔的抗原丢失构成了重要的逃逸机制。从一个逃脱排斥的肿瘤-克隆中丢失变异特异性抗原决定簇,使得能够检测到残留的变异特异性决定簇。通过分离一个新的CTL克隆证明了这一点,该克隆既能裂解原始肿瘤-克隆及其抗原丢失变异体,又不能裂解其他P815靶标。因此,通过使用抗原丢失变异体,一些复杂的移植抗原可以被分离成独立的决定簇。